Buckeye Provider Guide for Quantitative Drug Testing for Drugs of Abuse Form

Chat with GenHealth to automate any policy or prior auth task.


Buckeye Provider Guide for Quantitative Drug Testing for Drugs of Abuse

Indications

(10001) Is prior authorization required for CPT code 80154? 
(20001) Is prior authorization required for CPT code 80184? 
(30001) Is prior authorization required for CPT code 82145? 
(40001) Is prior authorization required for CPT code 82205? 
(50001) Is prior authorization required for CPT code 82520? 

YesNoN/A
YesNoN/A
YesNoN/A

Sign up to see the rest of the questions

Unlock the remaining questions and the full coverage workflow.

Sign up for free
Effective Date

NA

Last Reviewed

NA

Original Document

  Reference



Buckeye Provider Guide

for Quantitative Drug Testing for Drugs of Abuse

Effective 11/1/14 Buckeye Community Health Plan will begin requiring prior authorization as a condition of payment for Quantitative Testing for Drugs of Abuse.

The ordering provider should request prior authorization for Quantitative Drug Testing for Drugs of Abuse. Refer to the information below for guidance regarding how to obtain prior authorizations from Buckeye.

FREQUENTLY ASKED QUESTIONS:

How do I determine if a test is a Quantitative Drug Test for Drugs of Abuse?

  • You may determine which specific codes require prior authorization by visiting our website at www.bchpohio.com and clicking on the Prior Auth Needed tab. The Prior Auth Needed tab will take you to our PreScreen Tool. Just enter the CPT code and the PreScreen Tool will advise you whether the service requires prior authorization or
  • The enclosed spreadsheet listing the updated codes which require prior authorization.

How do I request a prior authorization for these services?

  • You may submit the prior authorization request utilizing our Secure Web Portal at www.bchpohio.com. If your request is not approved, you will receive verification through the Secure Web Portal. If you are not currently registered on our Secure Web Portal, you may register through a quick and simple process.
  • You may submit the prior authorization request by faxing an authorization to:
    • Central/Southeast Region – Columbus PA Fax Number 855-339-5145
    • Northeast Region – Akron PA Fax Number 866-535-4083
    • Northeast Region – Cleveland PA Fax Number 866-529-0290
    • West Region – Cincinnati/Dayton PA Fax Number 866-529-0291
    • West Region – Toledo PA Fax Number 866-535-4084
    • The fax authorization form can be found on our website at www.bchpohio.com.
    • You may call our Medical Management department at 866-246-4359.

What information will I be required to submit in connection with the prior authorization request?

  • CPT code
  • Diagnosis Code
  • Rendering laboratory provider’s name, Tax ID number, and NPI number.

If you have any questions regarding this information, you may contact Provider Services at 866-296-8731 or www.bchpohio.com.

1

When the services below are Covered Services, the services require Prior Authorization.

CPT CODE DESCRIPTION
80154 DRUG SCREEN QUANTITATIVE BENZODIAZEPINES
80184 DRUG SCREEN QUANTITATIVE PHENOBARBITAL
82145 AMPHETAMINE OR METHAMPHETAMINE, CHEMICAL, QUANTITATIVE
82205 BARBITURATES; QUANTITATIVE
82520 COCAINE, QUANTITATIVE
82646 DIHYDROCODEINONE
82649 DIHYDROMORPHINONE, QUANTITATIVE
83805 MEPROBAMATE, BLOOD OR URINE
83840 METHADONE
83887 NICOTINE
83925 ASSAY OF OPIATES
83992 PHENCYCLIDINE (PCP)

2

When the services below are Covered Services, the services require Prior Authorization

CPT CODE DESCRIPTION
81161 DMD DUPLICATION/DELETION ANALYSIS
81200 ASPA GENE
81201 APC GENE ANALYSIS FULL GENE SEQUENCE
81202 APC GENE ANALYSIS KNOWN FAMILIAL VARIANTS
81203 APC GENE ANALYSIS DUPLICATION/DELETION VARIANTS
81205 BCKDHB GENE
81206 BCR/ABL1 GENE MAJOR BP
81207 BCR/ABL1 GENE MINOR BP
81208 BCR/ABL1 GENE OTHER BP
81209 BLM GENE
81210 BRAF GENE
81211 BRCA1&2 SEQ & COM DUP/DEL
81212 BRCA1&2 185&5385&6174 VAR
81213 BRCA1&2 UNCOM DUP/DEL VAR
81214 BRCA1 FULL SEQ & COM DUP/DEL
81215 BRCA1 GENE KNOWN FAM VARIANT
81216 BRCA2 GENE FULL SEQUENCE
81217 BRCA2 GENE KNOWN FAM VARIANT
81220 CFTR GENE COM VARIANTS
81221 CFTR GENE KNOWN FAM VARIANTS
81222 CFTR GENE DUP/DELET VARIANTS
81223 CFTR GENE FULL SEQUENCE
81224 CFTR GENE INTRON POLY T
81225 CYP2C19 GENE COM VARIANTS
81226 CYP2D6 GENE COM VARIANTS
81227 CYP2C9 GENE COM VARIANTS
81228 CYTOGEN MICRARRAY COPY NMBR
81229 CYTOGEN M ARRAY COPY NO&SNP
81235 EGFR GENE ANALYSIS COMMON VARIANTS
81240 F2 GENE
81241 F5 GENE
81242 FANCC GENE
81243 FMR1 GENE DETECTION
81244 FMR1 GENE CHARACTERIZATION
81245 FLT3 GENE
81250 G6PC GENE
81251 GBA GENE

3

CPT CODE DESCRIPTION
81252 GJB2 GENE ANALYSIS FULL GENE SEQUENCE
81253 GJB2 GENE ANALYSIS KNOWN FAMILIAL VARIANTS
81254 GJB6 GENE ANALYSIS COMMON VARIANTS
81255 HEXA GENE
81256 HFE GENE
81257 HBA1/HBA2 GENE
81260 IKBKAP GENE
81261 IGH GENE REARRANGE AMP METH
81262 IGH GENE REARRANG DIR PROBE
81263 IGH VARI REGIONAL MUTATION
81264 IGK REARRANGEABN CLONAL POP
81265 STR MARKERS SPECIMEN ANAL
81266 STR MARKERS SPEC ANAL ADDL
81267 CHIMERISM ANAL NO CELL SELEC
81268 CHIMERISM ANAL W/CELL SELECT
81270 JAK2 GENE
81275 KRAS GENE
81280 LONG QT SYND GENE FULL SEQ
81281 LONG QT SYND KNOWN FAM VAR
81282 LONG QT SYN GENE DUP/DLT VAR
81287 MGMT (O-6-methylguanine-DNA methyltransferase) (eg, glioblastoma multiforme), methylation analysis
81290 MCOLN1 GENE
81291 MTHFR GENE
81292 MLH1 GENE FULL SEQ
81293 MLH1 GENE KNOWN VARIANTS
81294 MLH1 GENE DUP/DELETE VARIANT
81295 MSH2 GENE FULL SEQ
81296 MSH2 GENE KNOWN VARIANTS
81297 MSH2 GENE DUP/DELETE VARIANT
81298 MSH6 GENE FULL SEQ
81299 MSH6 GENE KNOWN VARIANTS
81300 MSH6 GENE DUP/DELETE VARIANT
81301 MICROSATELLITE INSTABILITY
81302 MECP2 GENE FULL SEQ
81303 MECP2 GENE KNOWN VARIANT
81304 MECP2 GENE DUP/DELETE VARIANT
81310 NPM1 GENE
81315 PML/RARALPHA COM BREAKPOINTS

4

CPT CODE DESCRIPTION
81316 PML/RARALPHA 1 BREAKPOINT
81317 PMS2 GENE FULL SEQ ANALYSIS
81318 PMS2 KNOWN FAMILIAL VARIANTS
81319 PMS2 GENE DUP/DELET VARIANTS
81321 PTEN GENE ANALYSIS FULL SEQUENCE ANALYSIS
81322 PTEN GENE ANALYSIS KNOWN FAMILIAL VARIANT
81323 PTEN GENE ANALYSIS DUPLICATION/DELETION VARIANT
81324 PMP22 GENE ANAL DUPLICATION/DELETION ANALYSIS
81325 PMP22 GENE ANALYSIS FULL SEQUENCE ANALYSIS
81326 PMP22 GENE ANALYSIS KNOWN FAMILIAL VARIANT
81330 SMPD1 GENE COMMON VARIANTS
81331 SNRPN/UBE3A GENE
81332 SERPINA1 GENE
81340 TRB@ GENE REARRANGE AMPLIFY
81341 TRB@ GENE REARRANGE DIRPROBE
81342 TRG GENE REARRANGEMENT ANAL
81350 UGT1A1 GENE
81355 VKORC1 GENE
81370 HLA I & II TYPING LR
81371 HLA I & II TYPE VERIFY LR
81372 HLA I TYPING COMPLETE LR
81373 HLA I TYPING 1 LOCUS LR
81374 HLA I TYPING 1 ANTIGEN LR
81375 HLA II TYPING AG EQUIV LR
81376 HLA II TYPING 1 LOCUS LR
81377 HLA II TYPE 1 AG EQUIV LR
81378 HLA I & II TYPING HR
81379 HLA I TYPING COMPLETE HR
81380 HLA I TYPING 1 LOCUS HR
81381 HLA I TYPING 1 ALLELE HR
81382 HLA II TYPING 1 LOC HR
81383 HLA II TYPING 1 ALLELE HR
81400 MOPATH PROCEDURE LEVEL 1
81401 MOPATH PROCEDURE LEVEL 2
81402 MOPATH PROCEDURE LEVEL 3
81403 MOPATH PROCEDURE LEVEL 4
81404 MOPATH PROCEDURE LEVEL 5
81405 MOPATH PROCEDURE LEVEL 6
81406 MOPATH PROCEDURE LEVEL 7

5

CPT CODE DESCRIPTION
81407 MOPATH PROCEDURE LEVEL 8
81408 MOPATH PROCEDURE LEVEL 9
81479 UNLISTED MOLECULAR PATHOLOGY PROCEDURE
81500 ONCO (OVARIAN) BIOCHEMICAL ASSAY TWO PROTEINS
81503 ONCO (OVARIAN) BIOCHEMICAL ASSAY FIVE PROTEINS
81504 Oncology (tissue of origin), microarray gene expression profiling of > 2000 genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as tissue similarity scores
81506 ENDOCRINOLOGY BIOCHEMICAL ASSAY SEVEN ANAL
81507 Fetal aneuploidy (trisomy 21, 18, and 13) DNA sequence analysis of selected regions using maternal plasma, algorithm reported as a risk score for each trisomy
81508 FETAL CONGENITAL ABNOR ASSAY TWO PROTEINS
81509 FETAL CONGENITAL ABNOR ASSAY 3 PROTEINS
81510 FETAL CONGENITAL ABNOR ASSAY THREE ANAL
81511 FETAL CONGENITAL ABNOR ASSAY FOUR ANAL
81512 FETAL CONGENITAL ABNOR ASSAY FIVE ANAL
81599 UNLISTED MULTIANALYTE ASSAY ALGORITHMIC ANALYSIS
83890 MOLECULE ISOLATE
83891 MOLECULE ISOLATE NUCLEIC
83892 MOLECULAR DIAGNOSTICS
83893 MOLECULE DOT/SLOT/BLOT
83894 MOLECULE GEL ELECTROPHOR
83896 MOLECULAR DX; NUCLEIC ACID PROBE EA
83897 MOLECULE NUCLEIC TRANSFER
83898 MOLECULAR DX AMPLIFICATION TARGET EA SEQUENCE
83900 MOLECULAR DX AMP TARGET MULTIPLEX 1ST 2 SEQ
83901 MOLECULAR DX AMP TARGET MULTIPLEX EA ADDL SEQ
83902 MOLECULAR DX; REVERSE TRANSCRIPTION
83903 MOLEC DX; MUTATION SCAN BY PHYS PROP-1 SGMT EA
83904 MOLEC DX; MUTATION ID-SEQUENCING-1 SGMT EA
83905 MOLEC DX; MUTATION ID-ALLELE SPEC TRANSCRIP-1-EA
83906 MOLEC DX; MUTATION ID-ALLELE SPEC TRANSLAT-1-EA
83907 LYSE CELLS FOR NUCLEIC EXT
83908 MOLECULAR DX AMPLIFICATION SIGNAL EA SEQUENCE
83909 NUCLEIC ACID HIGH RESOLUTE
83912 MOLECULAR DX; INTERPT & REPORT
83913 RNA STABILIZATION
83914 MUTATION ID ENZYMATIC LIG/PRIMER XTN 1 SGM EA
83915 NUCLEOTIDASE 5'-
86812 TISSUE TYPING; HLA TYPING, A, B, OR C (EG, A10, B7, B27), SINGLE ANTIGEN

6

CPT CODE DESCRIPTION
86813 TISSUE TYPING; HLA TYPING, A, B, AND/OR C (EG, A10, B7, B27), MULTIPLE A
86816 TISSUE TYPING; HLA TYPING, DR/DQ, SINGLE ANTIGEN
86817 TISSUE TYPING; HLA TYPING, DR/DQ, MULTIPLE ANTIGENS
86821 TISSUE TYPING; LYMPHOCYTE CULTURE, MIXED(MLC)
86822 TISSUE TYPING; LYMPHOCYTE CULTURE, PRIMED(PLC)
86825 HLA X-MATCH, NON-CYTOTOXIC
86826 HLA X-MATCH, NON-CYT ADD-ON
86828 HLA CLASS I/II ANTIBODY QUAL
86829 HLA CLASS I/II ANTIBODY QUAL
86830 HLA CLASS I PHENOTYPE QUAL
86831 HLA CLASS II PHENOTYPE QUAL
86832 HLA CLASS I HIGH DEFIN QUAL
86833 HLA CLASS II HIGH DEFIN QUAL
86834 HLA CLASS II SEMIQUANT PANEL
86835 HLA CLASS II SEMIQUANT PANEL
88230 TISS CULTURE NON-NEOPLAS DISORD; LYMPHOCYTE
88233 TISS CULTURE NON-NEOPLAS DISORD; SKIN/SOLID TISS
88235 TISS CULTURE NON-NEOPLAS DISORD; AMNIOTIC FLUID
88237 TISS CULTURE NEOPLAS DISORD; MARROW/BLD CELLS
88239 TISS CULTURE NEOPLAS DISORD; SOLID TUMOR
88240 CRYOPRESERV-FREEZE & STORE CELLS EA CELL LINE
88241 THAWING & EXPANSION FROZEN CELLS EA ALIQUOT
88245 CHROMOSOME ANALY BREAK SYNDROM; SCE 20-25 CELLS
88248 CHROMOSOME ANALY; BASELINE BREAKAGE
88249 CHROMOSOME ANALY BREAK SYNDROM; CLASTOGEN STRESS
88261 CHROMO ANALY; CT 5 CELLS 1 KARYOTYPE W/BANDING
88262 CHROMO ANALY; CT 15-20 CELLS 2 KARYOTYPES W/BAND
88263 CHROMO ANALY; CT 45 CEL MOSAICISM 2 KARYO W/BAND
88264 CHROMOSOME ANALY; ANALY 20-25 CELLS
88267 CHROMO ANALY AMNIO FLUID CT 15 CELLS 1 KARYOTYPE
88269 CHROMO ANALY AMNIO FLUID CELLS CT 6-12 COLONIES
88271 MOLEC CYTOGEN; DNA PROBE EA
88272 MOLEC CYTOGEN; CHROMOSOM IN SITU HYBRID 3-5 CELL
88273 MOLEC CYTOGEN; CHROMOSOM HYBRID 10-30 CELLS
88274 MOLEC CYTOGEN; INTERPHASE IN SITU HYBRID 25-99
88275 MOLEC CYTOGEN; INTERPHASE IN SITU HYBRID 100-300
88280 CHROMOSOME ANALY; ADD KARYOTYPES EA STUDY
88283 CHROMOSOME ANALY; ADD SPECIALIZED BANDING TECH
88285 CHROMOSOME ANALY; ADD CELLS COUNTED EA STUDY

7

CPT CODE DESCRIPTION
88289 CHROMOSOME ANALY; ADD HIGH RESOLUTION STUDY
88291 CYTOGEN & MOLEC CYTOGEN INTERPT & REPORT
88299 UNLISTED CYTOGENETIC STUDY
88384 RA-BASED EVAL MLT MOLEC PRBS 11 THRU 50 PRBS
88385 RA-BASED EVAL MLT MOLEC PRBS 51 THRU 250 PRBS
88386 RA-BASED EVAL MLT MOLEC PRBS 251 THRU 500 PRBS
S3713 KRAS MUTATION ANALYSIS
S3800 GENETIC TESTING FOR AMYOTROPHIC LATERAL SCLEROSIS (ALS)
S3818 COMPLETE GENE SEQUENCE ANALYSIS
S3819 COMPLETE GENE SEQUENCE ANALYSIS
S3820 COMPLETED BRCA1 AND BRCA2 GENE SEQUENCE ANALYSIS FOR SUSCEP
S3822 SINGLE MUTATION ANALYSIS FOR SUSCEP TO BREAST AND OVARION CANCER
S3823 3-MUTATION ANALYSIS FOR SUSCEP/BREAST &OVARION CANCER IN ASHKENAZI INDI
S3828 COMPLETE GENE SEQUENCE ANALYSIS, MLH1 GENE
S3829 COMPLETE GENE SEQUENCE ANALYSIS, MLH2 GENE
S3830 COMPLETE MLH1 AND MLH2 GENE SEQUENCE ANALYSIS
S3831 SINGLE MUTATION ANALYSIS
S3833 COMPLETE APC GENE SEQUENCE ANAL/SUSCEPTIBILITY TO (FAP)
S3834 SINGLE-MUTATION ANALYSIS /SUSCEPTIBILITY TO (FAP)&ATTENUATED FAP
S3835 COMPLETE GENE SEQUENCE ANALYSIS FOR CYSTIC FIBROSIS GENETIC TESTING
S3837 COMPLETE GENE SEQUENCE ANALYSIS FOR HEMOCHROMATOSIS GENETIC TESTING
S3840 DNA ANALYSIS FOR GERMLINE MUTATIONS OF THE RET PROTO-ONCOGENE
S3841 GENETIC TESTING FOR RETINOBLASTOMA
S3842 GENETIC TESTING FOR VON HIPPEL-LINDAU DISEASE
S3843 DNA ANALYSIS OF THE F5 GENE FOR SUSCEP TO FACTOR V LEIDEN THROMBOPHILIA
S3844 DNA ANLYSIS/CONNEXIN 26 GENE (GJB2)/SUSCEP/CONGENITAL, PRNDF DEAFNESS
S3845 GENETIC TESTING FOR ALPHA-THALASSEMIA
S3846 GENETICI TESTING FOR HEMOGLOBIN E BETA-THALASSEMIA
S3847 GENETIC TESTING FOR TAY-SACHS DISEASE
S3848 GENETIC TESTING FOR GAUCHER DISEASE
S3849 GENETIC TESTING FOR NIEMANN-PICK DISEASE
S3850 GENETIC TESTING FOR SICKLE CELL ANEMIA
S3851 GENETIC TESTING FOR CANAVAN DISEASE
S3852 DNA ANLYS/APOE EPILON 4 ALLELE FOR SUSCEP ALZHEIMER'S DISEASE
S3853 GENETIC TESTING FOR MYOTONIC MUSCULAR DYSTROPHY
S3854 GENE EXPRESSION PROFILING PANEL FOR US IN MGMT OF BREAST CANCER TRTMNT
S3855 GENETIC TESTING FOR DETECTION OF MUTATIONS IN THE PRESENILIN - 1 GENE
S3860 GENET TEST CARDIAC ION-COMP
S3861 GENETIC TEST BRUGADA

8

CPT CODE DESCRIPTION
S3862 GENET TEST CARDIAC ION-SPEC
S3865 COMP GENET TEST HYP CARDIOMY
S3866 SPEC GENE TEST HYP CARDIOMY
S3870 CGH TEST DEVELOPMENTAL DELAY
S3890 DNA ANALYSIS FECAL COLORECTAL CANCER SCREENING

9

Book a walkthrough

Walk through this policy with us

Review how this policy can be converted into cited criteria, prior authorization checks, and operational automation.